140 related articles for article (PubMed ID: 26774077)
21. Mosaic chromosome 5p tetrasomy: eye closure-induced seizures in a rare neurocutaneous syndrome.
Samanta D; Schaefer B
Acta Neurol Belg; 2020 Jun; 120(3):713-716. PubMed ID: 31292937
[No Abstract] [Full Text] [Related]
22. Late-onset gain of skills and peculiar jugular pit in an 11-year-old girl with 5q14.3 microdeletion including MEF2C.
Berland S; Houge G
Clin Dysmorphol; 2010 Oct; 19(4):222-224. PubMed ID: 20729728
[No Abstract] [Full Text] [Related]
23. RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.
Macmurdo CF; Wooderchak-Donahue W; Bayrak-Toydemir P; Le J; Wallenstein MB; Milla C; Teng JM; Bernstein JA; Stevenson DA
Am J Med Genet A; 2016 Jun; 170(6):1450-4. PubMed ID: 26969842
[TBL] [Abstract][Full Text] [Related]
24. Prenatal molecular diagnosis in RASA1-related disease.
Palmyre A; Eyries M; Senat MV; Ozanne A; Staraci S; Dufour P; Chinet T; Lacombe P; Soubrier F; Charron P
Prenat Diagn; 2017 Dec; 37(12):1261-1264. PubMed ID: 29025196
[TBL] [Abstract][Full Text] [Related]
25. [Genetic analysis of a case with MEF2C deletion in association with 5q14.3 microdeletion syndrome].
Zhou T; Su W; Liang D; Xu Y; Luo Y; Tong G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):779-782. PubMed ID: 34365624
[TBL] [Abstract][Full Text] [Related]
26. Multiple arteriovenous malformations caused by RASA1 gene mutation presenting during pregnancy - a case report and review of the literature.
Manzocchi Besson S; Jastrow Meyer N; Bounameaux H; La Scala GC; Calza AM; Yilmaz H; Righini M; Robert-Ebadi H
Vasa; 2019 May; 48(3):276-280. PubMed ID: 30526434
[No Abstract] [Full Text] [Related]
27. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
Tonk V; Kyhm JH; Gibson CE; Wilson GN
Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.
Burrows PE; Gonzalez-Garay ML; Rasmussen JC; Aldrich MB; Guilliod R; Maus EA; Fife CE; Kwon S; Lapinski PE; King PD; Sevick-Muraca EM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8621-6. PubMed ID: 23650393
[TBL] [Abstract][Full Text] [Related]
29. Multifocal capillary malformations in an older, asymptomatic child with a novel RASA1 mutation.
Whitaker S; Leech S; Taylor A; Splitt M; Natarajan S; Rajan N
Clin Exp Dermatol; 2016 Mar; 41(2):156-8. PubMed ID: 26132338
[TBL] [Abstract][Full Text] [Related]
30. Genetic Evaluation of Common Neurocutaneous Syndromes.
Gürsoy S; Erçal D
Pediatr Neurol; 2018 Dec; 89():3-10. PubMed ID: 30424961
[TBL] [Abstract][Full Text] [Related]
31. The genetics of vascular anomalies.
Frigerio A; Stevenson DA; Grimmer JF
Curr Opin Otolaryngol Head Neck Surg; 2012 Dec; 20(6):527-32. PubMed ID: 22913934
[TBL] [Abstract][Full Text] [Related]
32. [Cutaneous hemangiomas, vascular malformations and associated disorders. A new neurocutaneous syndrome].
Pascual-Castroviejo I; López-Gutiérrez JC; Pascual-Pascual SI; Rafia S; Alarcón-Palacio J
An Pediatr (Barc); 2003 Apr; 58(4):339-49. PubMed ID: 12681183
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene.
de Wijn RS; Oduber CE; Breugem CC; Alders M; Hennekam RC; van der Horst CM
Eur J Med Genet; 2012 Mar; 55(3):191-5. PubMed ID: 22342634
[TBL] [Abstract][Full Text] [Related]
34. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.
Paciorkowski AR; Traylor RN; Rosenfeld JA; Hoover JM; Harris CJ; Winter S; Lacassie Y; Bialer M; Lamb AN; Schultz RA; Berry-Kravis E; Porter BE; Falk M; Venkat A; Vanzo RJ; Cohen JS; Fatemi A; Dobyns WB; Shaffer LG; Ballif BC; Marsh ED
Neurogenetics; 2013 May; 14(2):99-111. PubMed ID: 23389741
[TBL] [Abstract][Full Text] [Related]
35. Multiple capillary malformations of progressive onset: Capillary malformation-arteriovenous malformation syndrome (CM-AVM).
Gourier G; Audebert-Bellanger S; Vourc'h P; Fraitag S; L'Hérondelle K; Labouche A; Misery L; Abasq-Thomas C
Ann Dermatol Venereol; 2018; 145(8-9):486-491. PubMed ID: 30056992
[TBL] [Abstract][Full Text] [Related]
36. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
37. RASA1 analysis: clinical and molecular findings in a series of consecutive cases.
Wooderchak-Donahue W; Stevenson DA; McDonald J; Grimmer JF; Gedge F; Bayrak-Toydemir P
Eur J Med Genet; 2012 Feb; 55(2):91-5. PubMed ID: 22200646
[TBL] [Abstract][Full Text] [Related]
38. Heredity of port-wine stains: investigation of families without a RASA1 mutation.
Troilius Rubin A; Lauritzen E; Ljunggren B; Revencu N; Vikkula M; Svensson Å
J Cosmet Laser Ther; 2015; 17(4):204-8. PubMed ID: 25602354
[TBL] [Abstract][Full Text] [Related]
39. A spectrum of intracranial vascular high-flow arteriovenous shunts in RASA1 mutations.
Grillner P; Söderman M; Holmin S; Rodesch G
Childs Nerv Syst; 2016 Apr; 32(4):709-15. PubMed ID: 26499346
[TBL] [Abstract][Full Text] [Related]
40. Neurocutaneous Syndromes and Brain Tumors.
Ullrich NJ
J Child Neurol; 2016 Oct; 31(12):1399-411. PubMed ID: 26459515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
